Full text is available at the source.
Abstract
Neural circuits may be major targets for incretin-mimetic drugs in obesity treatment.
- Incretin-mimetic drugs are linked to changes in energy balance and metabolism.
- Central and peripheral pathways could play significant roles in regulating metabolic processes.
- Ongoing research aims to identify specific mechanisms for effectively targeting these pathways.
- Further investigation is needed to optimize therapeutic approaches for obesity management.
Simplified